1Devi K, George S, Criton S,et al. Carbamazepine - the commonest cause of toxic epidermal necrolysis and Stevens- Johnson syndrome: A study of 7 years [ J ]. Indian J Dermatol Venereol Leprol,2005,71 (5) :325 - 328.
1Chislain PD,Roujeau JC.Treatment of severe drug reactions:Stevens-Johnson syndrome,toxic epidermal necrolysis and hypersensitivity syndrome[J].Dermatol Online J,2002,8:5
2Allende Bandres MA,Izuel Rami M,Urbieta Sanz E,et al.Cross-hypersensitivity syndrome between antiepileptic drugs:report of a case[J].Farm Hosp,2004,28(1):56 ～ 58
3Tas S,Simonart T.Management of drug rash with eosinophilia and systemic symptons (DRESS symptons):an update[J].Dermatology,2003,206(4):353 ～ 356
5Neff P,MeuLi-si mmen C,Kempf W,et al.Lyell syndrome revisited:analysis of 18 cases of severe bullous skin disease in a burns unit[J].Br J Plast Surg,2005,58(1):73 ～ 80
7Bachot N,Revuz J,Roujeau JC.Intravenous immunoglobulin treatment for stevens-Johnson syndrome and toxic epidermal necrolysis:a prospective noncomparative study showing no benefit on mortality or progression[J].Arch Dermatol,2003,139(1):33 ～ 36
9Krueger JG. The immunologic basis for the treatment of psoriasis with new Biologic agents [ J ]. J Am Acad Dermatol,2002,46 ( 1 ): 1-23.
10Yang Y, Yu YT, Song JC, et al. A new DNA immune adsorbent for hemoperfusion in SLE therapy : a clinical trial [ J ] . Artif Organs, 1988, 12 (5) : 444-446.
